WOLVERINE ASSET MANAGEMENT LLC - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 5 filers reported holding UNITED THERAPEUTICS CORP DEL in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q3 2015$4,208,000
-37.5%
1,534,000
-17.1%
0.10%
-35.3%
Q2 2015$6,731,000
-95.4%
1,850,000
-95.5%
0.15%
-94.8%
Q1 2015$146,884,000
+38.3%
40,750,000
+3.8%
2.93%
+41.7%
Q4 2014$106,189,000
+0.7%
39,250,0000.0%2.07%
-6.1%
Q3 2014$105,446,000
+42.4%
39,250,0000.0%2.20%
+35.8%
Q2 2014$74,033,000
-4.9%
39,250,0000.0%1.62%
-2.7%
Q1 2014$77,831,000
+228.2%
39,250,000
+292.5%
1.67%
+255.2%
Q4 2013$23,713,000
+39.7%
10,000,0000.0%0.47%
+24.1%
Q3 2013$16,978,000
-41.6%
10,000,000
-50.0%
0.38%
-49.1%
Q2 2013$29,065,00020,000,0000.74%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q4 2015
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders